Sökning: WFRF:(Scherstén Anders) > Bivalirudin versus ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 12607naa a2200997 4500 | |
001 | oai:DiVA.org:oru-61701 | |
003 | SwePub | |
008 | 171113s2017 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-140649 | |
009 | oai:DiVA.org:uu-336480 | |
009 | oai:prod.swepub.kib.ki.se:136678815 | |
009 | oai:lup.lub.lu.se:e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb8 | |
009 | oai:DiVA.org:liu-141843 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-617012 URI |
024 | 7 | a https://doi.org/10.1056/NEJMoa17064432 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1406492 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3364802 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1366788152 URI |
024 | 7 | a https://lup.lub.lu.se/record/e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb82 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1418432 URI |
040 | a (SwePub)orud (SwePub)umud (SwePub)uud (SwePub)kid (SwePub)lud (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Erlinge, D.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)kard-der |
245 | 1 0 | a Bivalirudin versus Heparin Monotherapy in Myocardial Infarction |
264 | 1 | b Massachusetts Medical Society,c 2017 |
338 | a print2 rdacarrier | |
500 | a Funding agencies:AstraZeneca and the Medicines Company | |
500 | a Funding Agencies|Swedish Heart-Lung Foundation; Swedish Research Council; AstraZeneca; Medicines Company; Swedish Foundation for Strategic Research (as part of the TOTAL-AMI project) | |
520 | a Background The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and administration of potent P2Y12 inhibitors without the planned use of glycoprotein IIb/IIIa inhibitors. Methods In this multicenter, randomized, registry-based, open-label clinical trial, we enrolled patients with either ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving treatment with a potent P2Y12 inhibitor (ticagrelor, prasugrel, or cangrelor) without the planned use of glycoprotein IIb/IIIa inhibitors. The patients were randomly assigned to receive bivalirudin or heparin during PCI, which was performed predominantly with the use of radial-artery access. The primary end point was a composite of death from any cause, myocardial infarction, or major bleeding during 180 days of follow-up. Results A total of 6006 patients (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial. At 180 days, a primary end-point event had occurred in 12.3% of the patients (369 of 3004) in the bivalirudin group and in 12.8% (383 of 3002) in the heparin group (hazard ratio, 0.96; 95% confidence interval [CI], 0.83 to 1.10; P=0.54). The results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups. Myocardial infarction occurred in 2.0% of the patients in the bivalirudin group and in 2.4% in the heparin group (hazard ratio, 0.84; 95% CI, 0.60 to 1.19; P=0.33), major bleeding in 8.6% and 8.6%, respectively (hazard ratio, 1.00; 95% CI, 0.84 to 1.19; P=0.98), definite stent thrombosis in 0.4% and 0.7%, respectively (hazard ratio, 0.54; 95% CI, 0.27 to 1.10; P=0.09), and death in 2.9% and 2.8%, respectively (hazard ratio, 1.05; 95% CI, 0.78 to 1.41; P=0.76). Conclusions Among patients undergoing PCI for myocardial infarction, the rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among those who received heparin monotherapy. (Funded by the Swedish Heart-Lung Foundation and others; VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu number, 2012-005260-10 ; ClinicalTrials.gov number, NCT02311231 .). | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
700 | 1 | a Omerovic, Elmiru Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut |
700 | 1 | a Fröbert, Ole,d 1964-u Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden,Rebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden.4 aut0 (Swepub:oru)oft |
700 | 1 | a Linder, Rikardu Karolinska Institutet,Danderyd Hospital, Sweden4 aut |
700 | 1 | a Danielewicz, Mikaelu PCI-Unit at Karlstad Hospital, Karlstad, Sweden,Karlstad Hosp, PCI Unit, Karlstad, Sweden.4 aut |
700 | 1 | a Hamid, Mehmetu Department of Cardiology, Mälarsjukhuset, Eskilstuna, Sweden,Malarsjukhuset, Dept Cardiol, Eskilstuna, Sweden.4 aut |
700 | 1 | a Swahn, Evau Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US4 aut0 (Swepub:liu)evasw45 |
700 | 1 | a Henareh, Loghmanu Karolinska Institutet,Karolinska University Hospital, Sweden4 aut |
700 | 1 | a Wagner, H.u Department of Cardiology, Helsingborg Lasarett, Helsingborg, Sweden,Helsingborg Lasarett, Dept Cardiol, Helsingborg, Sweden.,Helsingborg Hospital4 aut0 (Swepub:lu)med-hkw |
700 | 1 | a Hårdhammar, Peteru Department of Cardiology, Halmstad Hospital, Halmstad, Sweden,Halmstad Cty Hosp, Dept Cardiol, Halmstad, Sweden.,Halmstad County Hospital, Sweden4 aut |
700 | 1 | a Sjögren, Iwaru Department of Cardiology, Falun Hospital, Falun, Sweden,Falun Cent Hosp, Dept Cardiol, Falun, Sweden.,Falun Central Hospital, Sweden4 aut |
700 | 1 | a Stewart, Jasonu Department of Cardiology, Skaraborgs Hospital, Skövde, Sweden,Skaraborgs Hosp, Dept Cardiol, Skovde, Sweden.4 aut |
700 | 1 | a Grimfjärd, Peru Department of Internal Medicine, Västmanlands Sjukhus, Västerås, Sweden,Vastmanlands Sjukhus, Dept Internal Med, Vasteras, Sweden.,Västmanland Hospital4 aut |
700 | 1 | a Jensen, Jensu Umeå University,Karolinska Institute,Karolinska Institutet,Karolinska Institute, Sweden,Sunderby Sjukhus, Sweden,Umeå University, Sweden4 aut |
700 | 1 | a Aasa, Mikaelu Department of Cardiology, Södersjukhuset AB, Stockholm, Sweden,Sodersjukhuset AB, Dept Cardiol, Stockholm, Sweden.,Stockholm South General Hospital4 aut |
700 | 1 | a Robertsson, Lottau Department of Internal Medicine, Västmanlands Sjukhus, Västerås, Sweden,Sodra Alvsborgs Sjukhus, Dept Cardiol, Boras, Sweden.,South Elfsborg Hospital4 aut |
700 | 1 | a Lindroos, Pontusu Department of Cardiology, Capio St. Görans Hospital, Karolinska Institutet, Stockholm, Sweden,Karolinska Inst, Capio St Gorans Hosp, Dept Cardiol, Stockholm, Sweden.,Capio St. Görans Sjukhus4 aut |
700 | 1 | a Haupt, Janu Department of Cardiology, Sunderby Sjukhus, Luleå, Sweden,Sunderby Hospital4 aut |
700 | 1 | a Wikström, Helenau Department of Cardiology, Kristianstad Hospital, Kristianstad, Sweden,Kristianstad Hosp, Dept Cardiol, Kristianstad, Sweden.,Central Hospital Kristianstad4 aut |
700 | 1 | a Ulvenstam, Andersu Umeå universitet,Avdelningen för medicin,Ostersund Hosp, Dept Cardiol, Ostersund, Sweden.,Östersund Hospital, Sweden4 aut0 (Swepub:umu)anul0039 |
700 | 1 | a Bhiladvala, P.u Lund University,Lunds universitet,Kardiologiska klinikens forskargrupp,Forskargrupper vid Lunds universitet,Cardiology Research Group,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)medf-pbh |
700 | 1 | a Lindvall, Bou Department of Cardiology, Sundsvall Hospital, Sundsvall, Sweden,Sundsvall Hosp, Dept Cardiol, Sundsvall, Sweden.4 aut |
700 | 1 | a Lundin, Andersu Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden,Lund Univ, Dept Cardiol Clin Sci, Lund, Sweden.4 aut |
700 | 1 | a Tödt, T.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden,Sahlgrens University Hospital, Sweden,Örebro University, Sweden4 aut0 (Swepub:lu)med-ttt |
700 | 1 | a Ioanes, Danu Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut |
700 | 1 | a Råmunddal, Trulsu Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut |
700 | 1 | a Kellerth, Thomasu Örebro University4 aut |
700 | 1 | a Zagozdzon, Leszeku Örebro University,Örebro University, Sweden4 aut |
700 | 1 | a Götberg, M.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden4 aut0 (Swepub:lu)kard-mgo |
700 | 1 | a Andersson, Jonasu Umeå universitet,Kardiologi4 aut0 (Swepub:umu)joan0102 |
700 | 1 | a Angerås, Oskaru Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut |
700 | 1 | a Östlund, Ollieu Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Uppsala University, Sweden4 aut0 (Swepub:uu)oos27600 |
700 | 1 | a Lagerqvist, Bo,d 1952-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)bolager |
700 | 1 | a Held, Claes,d 1956-u Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)clahe947 |
700 | 1 | a Wallentin, Lars,d 1943-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)larswall |
700 | 1 | a Scherstén, F.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden4 aut0 (Swepub:lu)med-fds |
700 | 1 | a Eriksson, Peteru Umeå University,Umeå universitet,Kardiologi,Umea Univ, Dept Cardiol, Umea, Sweden.,Umeå University, Sweden4 aut0 (Swepub:umu)ernper00 |
700 | 1 | a Koul, S.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)med-sku |
700 | 1 | a James, Stefan,d 1964-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)stjam367 |
700 | 1 | a Linder, Robert,d 1981-u Umeå universitet,Lungmedicin4 aut0 (Swepub:umu)rotlir03 |
700 | 1 | a Abdel-Hamid, Mohamedu Mälar Hospital4 aut |
700 | 1 | a Östlund, Olofu Uppsala University Hospital4 aut |
710 | 2 | a Kardiologib Sektion II4 org |
773 | 0 | t New England Journal of Medicined : Massachusetts Medical Societyg 377:12, s. 1132-1142q 377:12<1132-1142x 0028-4793x 1533-4406 |
856 | 4 | u http://dx.doi.org/10.1056/NEJMoa1706443y FULLTEXT |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1147969/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-61701 |
856 | 4 8 | u https://doi.org/10.1056/NEJMoa1706443 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-140649 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-336480 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:136678815 |
856 | 4 8 | u https://lup.lub.lu.se/record/e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb8 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141843 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy